Anti-MRVI1 monoclonal antibody

Pre-made anti-MRVI1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MRVI1/MRVI1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1213-Ab-1/ GM-Tg-hg-IP1213-Ab-2Anti-Human MRVI1 monoclonal antibodyHuman
GM-Tg-rg-IP1213-Ab-1/ GM-Tg-rg-IP1213-Ab-2Anti-Rat MRVI1 monoclonal antibodyRat
GM-Tg-mg-IP1213-Ab-1/ GM-Tg-mg-IP1213-Ab-2Anti-Mouse MRVI1 monoclonal antibodyMouse
GM-Tg-cynog-IP1213-Ab-1/ GM-Tg-cynog-IP1213-Ab-2Anti-Cynomolgus/ Rhesus macaque MRVI1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1213-Ab-1/ GM-Tg-felg-IP1213-Ab-2Anti-Feline MRVI1 monoclonal antibodyFeline
GM-Tg-cang-IP1213-Ab-1/ GM-Tg-cang-IP1213-Ab-2Anti-Canine MRVI1 monoclonal antibodyCanine
GM-Tg-bovg-IP1213-Ab-1/ GM-Tg-bovg-IP1213-Ab-2Anti-Bovine MRVI1 monoclonal antibodyBovine
GM-Tg-equg-IP1213-Ab-1/ GM-Tg-equg-IP1213-Ab-2Anti-Equine MRVI1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1213-Ab-1/ GM-Tg-hg-IP1213-Ab-2; GM-Tg-rg-IP1213-Ab-1/ GM-Tg-rg-IP1213-Ab-2;
GM-Tg-mg-IP1213-Ab-1/ GM-Tg-mg-IP1213-Ab-2; GM-Tg-cynog-IP1213-Ab-1/ GM-Tg-cynog-IP1213-Ab-2;
GM-Tg-felg-IP1213-Ab-1/ GM-Tg-felg-IP1213-Ab-2; GM-Tg-cang-IP1213-Ab-1/ GM-Tg-cang-IP1213-Ab-2;
GM-Tg-bovg-IP1213-Ab-1/ GM-Tg-bovg-IP1213-Ab-2; GM-Tg-equg-IP1213-Ab-1/ GM-Tg-equg-IP1213-Ab-2
Products NameAnti-MRVI1 monoclonal antibody
Formatmab
Target NameMRVI1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MRVI1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1213-Ag-1Recombinant multi-species IRAG1/ MRVI1/ IRAG protein


    Target information

    Target IDGM-IP1213
    Target NameMRVI1
    Gene ID10335,17540,308899,702830,100855453,101088106,281918,100071324
    Gene Symbol and SynonymsIRAG,IRAG1,JAW1L,MRVI1,Ris1
    Uniprot AccessionQ9Y6F6,Q9N1F0
    Uniprot Entry NameIRAG1_HUMAN,IRAG1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000072952
    Target ClassificationN/A

    The target: MRVI1, gene name: MRVI1, also named as IRAG, JAW1L. This gene is similar to a putative mouse tumor suppressor gene (Mrvi1) that is frequently disrupted by mouse AIDS-related virus (MRV). The encoded protein, which is found in the membrane of the endoplasmic reticulum, is similar to Jaw1, a lymphoid-restricted protein whose expression is down-regulated during lymphoid differentiation. This protein is a substrate of cGMP-dependent kinase-1 (PKG1) that can function as a regulator of IP3-induced calcium release. Studies in mouse suggest that MRV integration at Mrvi1 induces myeloid leukemia by altering the expression of a gene important for myeloid cell growth and/or differentiation, and thus this gene may function as a myeloid leukemia tumor suppressor gene. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene, and alternative translation start sites, including a non-AUG (CUG) start site, are used. [provided by RefSeq, May 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.